NCT04167163View on ClinicalTrials.gov

Abaloparatide Before Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

April 3, 2025

Study Completion Date

April 3, 2025

Conditions
OsteoporosisArthroplasties, Knee Replacement
Interventions
DRUG

Abaloparatide

18 month ABL treatment

Trial Locations (1)

53705

University of Wisconsin, Madison

All Listed Sponsors
collaborator

Radius Health, Inc.

INDUSTRY

lead

University of Wisconsin, Madison

OTHER

NCT04167163 - Abaloparatide Before Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter